Histological and Immunohistochemical Evaluation of Ductal Carcinoma In Situ Co-Existing with Triple-Negative Carcinoma of the Breast
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Background : Triple-negative breast carcinomas (TNBCs) are associated with high-grade histological tumor and a poor clinical outcome. In this study, we evaluated the histology and immunohistochemical features of DCIS co-existing with TNBC to determine the characteristics of the precursor lesions of TNBC. Methods : Among the 1,610 cases of breast carcinoma, we selected the TNBCs with DCIS (n=196), and compared the pathological and immunohistochemical findings of the DCIS with those of the invasive carcinoma areas. Results : Among the 1,610 breast carcinomas, the TNBCs accounted for 330 cases (20.5%) and there were 196 cases with DCIS. The TN-DCIS cases exhibited high nuclear (94.5%) and histological (94.5%) grades, comedo-necrosis (68.9%) and a small extent of the DCIS-involved area. Immunohistochemically, a p53 expression was present in 48.4% of the TN-DCIS cases and a high Ki-67 index was present in 31.5%. The same TN immunohistochemical profiles as the carcinoma were detected in 109 of the 124 (87.9%) cases, but different profiles were observed in 15 of the 124 (12.1%) cases. The 15 discordant cases were associated with a low histological grade (p=0.037), low p53-positivity (p=0.006) and a low Ki-67 index (p=0.026), as compared to the invasive carcinomas. Conclusions : The results of this study suggest that TN DCIS is a highly probable, but not obligate, precursor lesion of TNBC.
Abstract
Background : Triple-negative breast carcinomas (TNBCs) are associated with high-grade histological tumor and a poor clinical outcome. In this study, we evaluated the histology and immunohistochemical features of DCIS co-existing with TNBC to determine the characteristics of the precursor lesions of TNBC. Methods : Among the 1,610 cases of breast carcinoma, we selected the TNBCs with DCIS (n=196), and compared the pathological and immunohistochemical findings of the DCIS with those of the invasive carcinoma areas. Results : Among the 1,610 breast carcinomas, the TNBCs accounted for 330 cases (20.5%) and there were 196 cases with DCIS. The TN-DCIS cases exhibited high nuclear (94.5%) and histological (94.5%) grades, comedo-necrosis (68.9%) and a small extent of the DCIS-involved area. Immunohistochemically, a p53 expression was present in 48.4% of the TN-DCIS cases and a high Ki-67 index was present in 31.5%. The same TN immunohistochemical profiles as the carcinoma were detected in 109 of the 124 (87.9%) cases, but different profiles were observed in 15 of the 124 (12.1%) cases. The 15 discordant cases were associated with a low histological grade (p=0.037), low p53-positivity (p=0.006) and a low Ki-67 index (p=0.026), as compared to the invasive carcinomas. Conclusions : The results of this study suggest that TN DCIS is a highly probable, but not obligate, precursor lesion of TNBC.
참고문헌 (25)
- Perou CM, "Molecular portraits of human breast tumours", Nature, 406, pp.747~752 (2000)
- Sorlie T, "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications", Proc Natl Acad Sci U S A, 98, pp.10869~10874 (2001)
- Sorlie T, "Repeated observation of breast tumor subtypes in independent gene expression data sets", Proc Natl Acad Sci U S A, 100, pp.8418~8423 (2003)
- Nielsen TO, "Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma", Clin Cancer Res, 10, pp.5367~5374 (2004)
- Carey LA, "Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study", JAMA, 295, pp.2492~2502 (2006)
- Cheang MC, "Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype", Clin Cancer Res, 14, pp.1368~1376 (2008)
- Abd El-Rehim DM, "High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses", Int J Cancer, 116, pp.340~350 (2005)
- Abd El-Rehim DM, "Expression of luminal and basal cytokeratins in human breast carcinoma", J Pathol, 203, pp.661~671 (2004)
- Tang P, "Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?", Hum Pathol, 39, pp.506~513 (2008)
- Rakha EA, "Prognostic markers in triple-negative breast cancer", Cancer, 109, pp.25~32 (2007)
- Cleator S, "Triple-negative breast cancer: therapeutic options", Lancet Oncol, 8, pp.235~244 (2007)
- Bryan BB, "Ductal carcinoma in situ with basallike phenotype: a possible precursor to invasive basal-like breast cancer", Mod Pathol, 19, pp.617~621 (2006)
- Livasy CA, "Identification of a basal-like subtype of breast ductal carcinoma in situ", Hum Pathol, 38, pp.197~204 (2007)
- Dabbs DJ, "Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile", Mod Pathol, 19, pp.1506~1511 (2006)
- Jacobs TW, "Specificity of HercepTest in determining HER-2", neu status of breast cancers using the United States Food and Drug Administration-approved scoring system, 1999, pp.17, 1983~1987
- Tischkowitz M, , BMC Cancer, 7, pp.134~ (2007)
- Livasy CA, "Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma", Mod Pathol, 19, pp.264~271 (2006)
- Millikan RC, "Epidemiology of basal-like breast cancer", Breast Cancer Res Treat, 109, pp.123~139 (2008)
- 이정훈, "면역조직화학적 염색에 의해 분류한 유방암 기저형과 내강형의 생존율 분석", 대한외과학회지, 70(1), pp.7~13 (2006), 대한외과학회
- Reis-Filho JS, "Triple negative tumours: a critical review", Histopathology, 52, pp.108~118 (2008)
- Reis-Filho JS, "Metaplastic breast carcinomas are basal-like tumours", Histopathology, 49, pp.10~21 (2006)
- Bertucci F, "Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers", Cancer Res, 66, pp.4636~4644 (2006)
- Steinman S, "Expression of cytokeratin markers, ER-alpha, PR, HER-2", neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast, 2007, pp.37, 127~134
- Wiechmann L, "The molecular journey from ductal carcinoma in situ to invasive breast cancer", Cancer, 112, pp.2130~2142 (2008)
- Allred DC, "Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution", Clin Cancer Res, 14, pp.370~378 (2008)